Skip to main content
SpringerLink
Log in

Carnitine transport: Pathophysiology and metabolism of known molecular defects

  • Published:
Journal of Inherited Metabolic Disease

Abstract

Summary: Early-onset dilatative and/or hypertrophic cardiomyopathy with episodic hypoglycaemic coma and very low serum and tissue concentrations of carnitine should alert the clinician to the probability of the plasmalemmal high-affinity carnitine transporter defect. The diagnosis can be established by demonstration of impaired carnitine uptake in cultured skin fibroblasts or lymphoblasts and confirmed by mutation analysis of the human OCTN2 gene in the affected child and obligate heterozygote parents. The institution of high-dose oral carnitine supplementation reverses the pathology in this otherwise lethal autosomal recessive disease of childhood, and carnitine therapy from birth in prospectively screened siblings may altogether prevent the development of the clinical phenotype. Heterozygotes may be at risk for cardiomyopathy in later adult life, particularly in the presence of additional risk factors such as hypertension and competitive pharmacological agents. OCTN2 belongs to a family of organic cation/carnitine transporters that function primarily in the elimination of cationic drugs and other xenobiotics in kidney, intestine, liver and placenta. The high- and low-affinity human carnitine transporters, OCTN2 and OCTN1, are multifunctional polyspecific organic cation transporters; therefore, defects in these transporters may have widespread implications for the absorption and/or elimination of a number of key pharmacological agents such as cephalosporins, verapamil, quinidine and valproic acid. A third organic/cation carnitine transporter with high specificity for carnitine, Octn3, has been clonedin mice. The juvenile visceral steatosis (jvs) mouse serves as an excellent clinical, biochemical and molecular model for the high-affinity carnitine transporter OCTN2 defect and is due to a spontaneous point mutation in the murine Octn2 gene on mouse chromosome 11, which is syntenic to the human locus at 5q31 that harbours the human OCTN2 gene.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  • Appleton RE, Farrell K, Applegarth DA, Dimmick JE, Wong LT, Davidson AG (1990) The high incidence of valproate hepatotoxicity in infants may relate to familial metabolic defects. Can J Neurol Sci. 17(2): 145-148.

    PubMed  CAS  Google Scholar 

  • Arduini A, Mancinelli G, Radatti GL, Dottori S, Molajoni F, Ramsay RR (1992) Role of carnitine and carnitine palmitoyltransferase as integral components of the pathway for membrane phospholipid fatty acid turnover in intact human erythrocytes. J Biol Chem 267(18): 12673-12681.

    PubMed  CAS  Google Scholar 

  • Ater SB, Swinyard EA, Tolman KG, Madsen JA, Matsuo F (1984) Effects of SKF525A, phenobarbital, fasting, and carnitine on the anticonvulsant activity and neurotoxicity of valproate in mice. Epilepsia 25: 599-604.

    PubMed  CAS  Google Scholar 

  • Bahl JJ, Bressler R (1987) The pharmacology of carnitine. Annu Rev Pharmacol Toxicol 27: 257-277.

    PubMed  CAS  Google Scholar 

  • Bahl J, Navin T, Manian A, Bressler R (1981) Carnitine transport in isolated adult rat heart myocytes and the effect of 7,8,-diOH chlorpromazine. Circ Res 48: 378-385.

    PubMed  CAS  Google Scholar 

  • Becker CM, Harris RA (1983) Influence of valproic acid on hepatic carbohydrate and lipid metabolism. Arch Biochem Biophys 223: 381-392.

    PubMed  CAS  Google Scholar 

  • Benavides J, Martin A, Ugarte M, Valdivieso F (1982) Inhibition by valproic acid of pyruvate uptake by brain mitochondria. Biochem Pharmacol 31: 1633-1636.

    PubMed  CAS  Google Scholar 

  • Bieber LL (1988) Carnitine. Annu Rev Biochem 57: 261-283.

    PubMed  CAS  Google Scholar 

  • Bohan TP, Helton E, McDonald I, et al (2001) Effect of L-carnitine treatment for valproate-induced hepatotoxicity. Neurology 56: 1405-1409.

    PubMed  CAS  Google Scholar 

  • Bohles H, Richter K, Wagner-Thiessen E, Schafer H (1982) Decreased serum carnitine in valproate induced Reye syndrome. Eur J Pediatr139:185 186.

    PubMed  CAS  Google Scholar 

  • Bremer J (1983) Carnitine metabolism and functions. Physiol Rev 63: 1420-1480.

    PubMed  CAS  Google Scholar 

  • Burckhardt G, Wolff NA (2000) Structure of renal organic anion and cation transporters. Am J Physiol Renal Physiol 278: F853 866.

    Google Scholar 

  • Burwinkel B, Kreuder J, Schweitzer S, et al (1999) Carnitine transporter OCTN2 mutations in systemic primary carnitine deficiency: a novel Argl69Gln mutation and a recurrent Arg282ter mutation associated with an unconventional splicing abnormality. Biochem Biophys Res Commun 261: 484-487.

    PubMed  CAS  Google Scholar 

  • Cederbaum SD, Koo-McCoy S, Tein I, et al (2002) Carnitine membrane transporter deficiency: a long-term follow up and OCTN2 mutation in the first documented case of primary carnitine deficiency. Mol Genet Metab 77: 195-201.

    PubMed  CAS  Google Scholar 

  • Christiansen RZ, Bremer J (1976) Active transport of butyrobetaine and carnitine into isolated liver cells. Biochim Biophys Acta 448: 562-577.

    PubMed  CAS  Google Scholar 

  • Corr PB, Creer MH, Yamada KA, Saffitz JE, Sobel BE (1989) Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation. J Clin Invest 83: 927-936.

    PubMed  CAS  Google Scholar 

  • Coulter DL (1991) Carnitine, valproate, and toxicity. J Child Neurol 6: 714.

    Google Scholar 

  • De Vivo DC, Tein I (1990) Primary and secondary disorders of carnitine metabolism. Int Pediatr 5: 134-141.

    Google Scholar 

  • Dreifuss FE, Santilli N, Langer DH, Sweeney KP, Moline KA, Menander KB (1987) Valproic acid hepatic fatalities: a retrospective review. Neurology 37: 379-385.

    PubMed  CAS  Google Scholar 

  • Engel AG, Rebouche CJ, Wilson DM, Glasgow AM, Romshe CA, Cruse RP (1981) Primary systemic carnitine deficiency. II. Renal handling of carnitine. Neurology 31: 819-825.

    PubMed  CAS  Google Scholar 

  • Englard S (1979) Hydroxylation of y-butyrobetaine to carnitine in human and monkey tissues. FEBS Lett 102: 297-300.

    PubMed  CAS  Google Scholar 

  • Eriksson BO, Gustafson B, Lindstedt S, Nordin I (1988) Hereditary defect in carnitine membrane transport is expressed in skin fibroblast. Eur J Pediatr 147: 662-663.

    PubMed  CAS  Google Scholar 

  • Eriksson BO, Gustafson B, Lindstedt S, Nordin I (1989) Transport of carnitine into cells in hereditary carnitine deficiency. J Inherit Metab Dis 12: 108-111.

    PubMed  CAS  Google Scholar 

  • Ganapathy ME, Huang W, Rajan DP, et al (2000)-Lactam antibiotics as substrates for OCTN2, an organic cation/carnitine transporter. J Biol Chem. 275(3): 1699 1707.

    PubMed  Google Scholar 

  • Garavaglia B, Uziel G, Dworzak F, Carrara F, DiDonato S (1991) Primary carnitine deficiency: heterozygote and intrafamilial phenotypic variation. Neurology 41: 1691-1693.

    PubMed  CAS  Google Scholar 

  • Gerber N, Dickinson RG, Harland RC, et al (1979) Reye-like syndrome associated with valproic acid therapy. J Pediatr 95: 142-144.

    PubMed  CAS  Google Scholar 

  • Haas R, Stumpf DA, Parks JK, Eguren L (1981) Inhibitory effects of sodium valproate on oxidative phosphorylation. Neurology 31: 1473-1476.

    PubMed  CAS  Google Scholar 

  • Hamilton JW, Li BUK, Shug A, Olsen WA (1983) Studies of L-carnitine absorption in man. Gastroeneterology 84(5 Pt 2): 1180.

    Google Scholar 

  • Hannuniemi R, Kontro P (1988) L-Carnitine uptake by mouse brain synaptosomal preparations: competitive inhibition by GABA. Neurochem Res 13: 317-323.

    PubMed  CAS  Google Scholar 

  • Holme E, Greter J, Jacobson CE, et al (1989) Carnitine deficiency induced by pivampicillin and pivmecillinam therapy. Lancet 2(8661): 469-473.

    PubMed  CAS  Google Scholar 

  • Horiuchi M, Kobayashi K, Yamaguchi S, et al (1994) Primary defect of juvenile visceral steatosis (jvs) mouse with systemic carnitine deficiency is probably in renal carnitine trans-port system. Biochim Biophys Acta 1226: 25-30.

    PubMed  CAS  Google Scholar 

  • Huth PJ, Shug A (1980) Properties of carnitine transport in rat kidney cortex slices. Biochim Biophys Acta 602: 621-634.

    PubMed  CAS  Google Scholar 

  • Huth PJ, Thomsen JH, Shug AL (1978) Carnitine transport by rat kidney cortex slices: stimulation by dibutyryl cyclic AMP. Life Sci 23: 715-722.

    PubMed  CAS  Google Scholar 

  • Huth PJ, Schmidt MG, Hall PV, Fariello RG, Shug AL (1981) The uptake of carnitine by slices of rat cerebral cortex. J Neurochem 36: 715-723.

    PubMed  CAS  Google Scholar 

  • Kaido M, Fujimura H, Ono A, et al (1997) Mitochondrial abnormalities in a murine model of primary carnitine deficiency. Eur Neurol 38: 302-309.

    PubMed  CAS  Google Scholar 

  • Kay JD, Hilton-Jones D, Hyman N (1986) Valproate toxicity and ornithine carbamoyl-transferase deficiency. Lancet 2: 1283-1284.

    PubMed  CAS  Google Scholar 

  • Kesterson JW, Granneman GR, Machinist JM (1984) The hepatotoxicity of valproic acid and its metabolites in rats. I. Toxicologic, biochemical and histopathologic studies. Hepatology 4: 1143-1152.

    PubMed  CAS  Google Scholar 

  • Kispal G, Melegh B, Alkonyi I, Sandor A (1987) Enhanced uptake of carnitine by perfused rat liver following starvation. Biochim Biophys Acta 896: 96-102.

    PubMed  CAS  Google Scholar 

  • Koizumi A, Nozaki J-I, Ohura T (1999) Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic carnitine deficiency. Hum Mol Genet 8: 2247-2254.

    PubMed  CAS  Google Scholar 

  • Koizumi T, Nikaido H, Hayakawa J, Nonomura A, Yoneda T (1988) Infantile disease with microvesicular fatty infiltration of viscera spontaneously occurring in the C3H-H-2°strain of mouse with similarities to Reye's syndrome. Lab Anim 22: 83-87.

    PubMed  CAS  Google Scholar 

  • Kuwajima M, Kono N, Horiuchi M, et al (1991) Animal model of systemic carnitine deficiency: analysis in C3H-H-2°strain of mouse associated with juvenile visceral steatosis. Biochem Biophys Res Commun 174: 1090-1094.

    PubMed  CAS  Google Scholar 

  • Kuwajima M, Lu K-M, Harashima H, et al (1996) Carnitine transport defect in fibroblasts of juvenile visceral steatosis (JVS) mouse. Biochem Biophys Res Commun 223: 283-287.

    PubMed  CAS  Google Scholar 

  • Kuwajima M, Horiuchi M, Harashima H, et al (1999) Cardiomegaly in the juvenile visceral steatosis (jvs) mouse is reduced with acute elevation of heart short-chain acyl-carnitine level after L-carnitine injection. FEBS Lett 443: 261-266.

    PubMed  CAS  Google Scholar 

  • Kyte J, Doolittle RF (1982) A simple method for displaying the hydropathic character of a protein. J Mol Biol 157: 105-132.

    PubMed  CAS  Google Scholar 

  • Lahjouji K, Elimrani I, Wu J, Mitchell GA, Qureshi IA (2002) A heterozygote phenotype is present in the jvs +/-mutant mouse livers. Mol Genet Metab 76: 76-80.

    PubMed  CAS  Google Scholar 

  • Lamhonwah AM, Tein I (1998) Carnitine uptake defect: frameshift mutations in the human plasmalemmal carnitine transporter gene. Biochem Biophys Res Commun 252: 396-401.

    PubMed  CAS  Google Scholar 

  • Lamhonwah AM, Tein I (1999) GFP-Human high-affinity carnitine transporter OCTN2 protein: subcellular localization and functional restoration of carnitine uptake in mutant cell lines with the carnitine transporter defect: Biochem Biophys Res Commun 264: 909-914.

    PubMed  CAS  Google Scholar 

  • Lamhonwah AM, Olpin SE, Pollitt RJ, et al (2002) Novel OCTN2 mutations: no genotype phenotype correlations: early carnitine therapy prevents cardiomyopathy. Am J Med Genet 111: 271-284.

    PubMed  Google Scholar 

  • Laub MC, Paetzke-Brunner I, Jaeger G (1986) Serum carnitine during valproic acid therapy. Epilepsia 27: 559-562.

    PubMed  CAS  Google Scholar 

  • Li J, Norwood DL, Mao LF, Schulz H (1991) Mitochondrial metabolism of valproic acid. Biochemistry 30: 388-394.

    PubMed  CAS  Google Scholar 

  • Lu K-M, Nishimori H, Nakamura Y, et al (1998) A missense mutation of mouse OCTN2, a sodium-dependent carnitine cotransporter, in the juvenile visceral steatosis mouse. Biochem Biophys Res Commun 252: 590-594.

    PubMed  CAS  Google Scholar 

  • Mak IT, Kramer JH, Weglicki WB (1986) Potentiation of free radical-induced lipid peroxidative injury to sarcolemmal membranes by lipid amphiphiles. J Biol Chem 261: 1153-1157.

    PubMed  CAS  Google Scholar 

  • Masuda M, Kobayashi K, Horiuchi M, et al (1997) A novel gene suppressed in the ventricle of carnitine-deficient juvenile visceral steatosis mice. FEBS Lett 408: 221-224.

    PubMed  CAS  Google Scholar 

  • Matsuda I, Ohtani Y (1986) Carnitine status in Reye and Reye-like syndromes. Pediatr Neurol 2: 90-94.

    PubMed  CAS  Google Scholar 

  • Mayatepek E, Nezu J, Tamai I, et al (2000) Two novel missense mutations of the OCTN2 gene (W283R and V446F) in a patient with primary systemic carnitine deficiency. Hum Mutat 15: 118 (Mutation in Brief (1999) 287, 14, Online).

    PubMed  CAS  Google Scholar 

  • McGarry JD, Mills SE, Long CS, Foster DW (1983) Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues. Biochem J 214: 21-28.

    PubMed  CAS  Google Scholar 

  • Melegh B, Kerner J, Kispal G, Acsadi G, Dani M (1987) Effect of chronic valproic acid treat-ment on plasma and urine carnitine levels in children: decreased urinary excretion. Acta Paediatr Hung 28: 137-142.

    PubMed  CAS  Google Scholar 

  • Millington DS, Bohan TP, Roe CR, Yergey AL, Liberato DJ (1985) Valproylcarnitine: a novel drug metabolite identified by fast atom bombardment and thermospray liquid chromatography mass spectrometry. Clin Chim Acta 145: 69-76.

    PubMed  CAS  Google Scholar 

  • Molstad P, Bohmer T, Eiklid K (1977) Specificity and characteristics of the carnitine transport in human heart cells (CCL 27) in culture. Biochim Biophys Acta 471: 296-304.

    PubMed  CAS  Google Scholar 

  • Morita J, Yuge K, Yoshino M (1986) Hypocarnitinemia in the handicapped individuals who receive a polypharmacy of antiepileptic drugs. Neuropediatrics 17: 203-235.

    PubMed  CAS  Google Scholar 

  • Murphy JV, Marquardt KM, Shug A (1984) Plasma and urine carnitine concentrations in patients receiving valproic acid. Pediatr Res 18: 340-(abstract).

    Google Scholar 

  • Murphy JV, Marquardt KM, Shug AL (1985) Valproic acid associated abnormalities of carnitine metabolism. Lancet 1: 820-821.

    PubMed  CAS  Google Scholar 

  • Nakajima T, Horiuchi M, Yamanaka H, et al (1997) The effect of carnitine on ketogenesis in perfused livers from juvenile visceral steatosis mice with systemic carnitine deficiency. Pediatr Res 42: 108-113.

    PubMed  CAS  Google Scholar 

  • Nezu J, Tamai I, Oku A, et al (1999) Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nature Genetics 21: 91-94.

    PubMed  CAS  Google Scholar 

  • Nikaido H, Horiuchi M, Hashimoto N, Saheki T, Hayakawa J (1995) Mapping of jvs (juvenile visceral steatosis) gene, which causes systemic carnitine deficiency in mice, on chromosome 11. Mamm Genome 6: 369-370.

    PubMed  CAS  Google Scholar 

  • Novak M, Monkus EF, Buch M, Lesmes H, Silverio J (1983) The effect of a L-carnitine supplemented soybean formula on the plasma lipids of infants. Acta Chir Scand 517 (supplement): 149-155.

    CAS  Google Scholar 

  • Ohashi R, Tamai I, Yabuuchi H, et al (1999) Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance. J. Pharmacol Exp Ther 291: 778-784.

    PubMed  CAS  Google Scholar 

  • Ohashi R, Tamai I, Inano A, et al (2002) Studies on functional sites of organic cation/carnitine transporter OCTN2 (SLC22A5) using a Ser467Cys mutant protein. J Pharmacol Exp Ther 302: 1286-1294.

    PubMed  CAS  Google Scholar 

  • Olson AL, Rebouche CJ (1987) y-Butyrobetaine hydroxylase activity is not rate limiting for carnitine biosynthesis in the human infant. J Nutr 117: 1024-1031.

    PubMed  CAS  Google Scholar 

  • Olson AL, Nelson SE, Rebouche CJ (1989) Low carnitine intake and altered lipid metabolism in infants. Am J Clin Nutr 49: 624-628.

    PubMed  CAS  Google Scholar 

  • Pons R, Carozza R, Tein I, et al (1997) Deficient muscle carnitine transport in primary carnitine deficiency. Pediatr Res 42: 583-587.

    PubMed  CAS  Google Scholar 

  • Pritchard JB, Miller DS (1993) Mechanisms mediating renal secretion of organic anions and cations. Physiol Rev 73: 765-796.

    PubMed  CAS  Google Scholar 

  • Ramsay RR, Gandour RD, van der Leij FR (2001) Molecular enzymology of carnitine transfer and transport. Biochim Biophys Acta 1546: 21-43.

    PubMed  CAS  Google Scholar 

  • Rashed MS, Ozand PT, Bennett MJ, Barnard JJ, Govindaraju DR, Rinaldo P (1995) Inborn errors of metabolism diagnosed in sudden death cases by acylcarnitine analysis of postmortem bile. Clin Chem 41: 1109-1114.

    PubMed  CAS  Google Scholar 

  • Rebouche CJ (1977) Carnitine movement across muscle cell membranes. Studies in isolated rat muscle. Biochim Biophys Acta 471: 145-155.

    PubMed  CAS  Google Scholar 

  • Rebouche CJ (1992) Carnitine function and requirements during the life cycle. FASEB J 6: 3379-3386.

    PubMed  CAS  Google Scholar 

  • Rebouche CJ, Chenard CA (1991) Metabolic fate of dietary carnitine in human adults: identi-fication and quantification of urinary and fecal metabolites. J Nutr 121: 539-546.

    PubMed  CAS  Google Scholar 

  • Rebouche CJ, Engel AG (1980) Tissue distribution of carnitine biosynthetic enzymes in man. Biochim Biophys Acta 630: 22-29.

    PubMed  CAS  Google Scholar 

  • Rebouche CJ, Engel AG (1982) Carnitine transport in cultured muscle cells and skin fibroblasts from patients with primary systemic carnitine deficiency. In Vitro 18: 495-500.

    PubMed  CAS  Google Scholar 

  • Rebouche CJ, Engel AG (1984) Kinetic compartmental analysis of carnitine metabolism in the human carnitine deficiency syndromes. Evidence for alterations in tissue carnitine transport. J Clin Invest 73: 857-867.

    PubMed  CAS  Google Scholar 

  • Rebouche CJ, Mack DL (1984) Sodium gradient-stimulated transport of L-carnitine into renal brush border membrane vesicles: kinetics, specificity, and regulation by dietary carnitine. Arch Biochem Biophys 235: 393-402.

    PubMed  CAS  Google Scholar 

  • Rinaldo P, Stanley CA, Hsu BY, Sanchez LA, Stern HJ (1997) Sudden neonatal death in carnitine transporter deficiency. J Pediatr 131: 304-305.

    PubMed  CAS  Google Scholar 

  • Rodriguez CM, Labus JC, Hinton BT (2002) Organic cation/carnitine transporter, OCTN2, is differentially expressed in the adult rat epididymis. Biol Reprod 67: 314-319.

    PubMed  CAS  Google Scholar 

  • Rodriguez-Segade S, de la Pena CA, Tutor JC, et al (1989) Carnitine deficiency associated with anticonvulsant therapy. Clin Chim Acta 181: 175-181.

    PubMed  CAS  Google Scholar 

  • Rumbach L, Warter JM, Rendon A, Marescaux C, Micheletti G, Waksman A (1983) Inhibition of oxidative phosphorylation in hepatic and cerebral mitochondria of sodium valproate-treated rats. J Neurol Sci 61: 417-423.

    PubMed  CAS  Google Scholar 

  • Saraste M, Sibbald PR, Wittinghofer A (1990) The P-loop a common motif in ATP-and GTP-binding proteins. Trends Biochem Sci 15: 430-434.

    PubMed  Google Scholar 

  • Schulz H, Fong JC (1981) 4-Pentenoic acid. Methods Enzymol 72: 604-610.

    PubMed  CAS  Google Scholar 

  • Shapira Y, Gutman A (1991) Muscle carnitine deficiency in patients using valproic acid. J Pediatr 118: 646-649.

    PubMed  CAS  Google Scholar 

  • Shoji Y, Koizumi A, Kayo T, et al (1998) Evidence for linkage of human primary systemic carnitine deficiency with D5S436: a novel gene locus on chromosome 5q. Am J Hum Genet 63: 101-108.

    PubMed  CAS  Google Scholar 

  • Stanley CA (1987) New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency. Adv Pediatr 34: 59-88.

    PubMed  CAS  Google Scholar 

  • Stanley CA, DeLeeuw S, Coates PM, et al (1991) Chronic cardiomyopathy and weakness or acute coma in children with a defect in carmitine uptake. Ann Neurol 30: 709-716.

    PubMed  CAS  Google Scholar 

  • Sugimoto T, Araki A, Nishida N, et al (1987) Hepatotoxicity in rat following administration of valproic acid: effect of L-carnitine supplementation. Epilepsia 28: 373-377.

    PubMed  CAS  Google Scholar 

  • Tamai I, Yabuuchi H, Nezu J, et al (1997) Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett 419: 107-111.

    PubMed  CAS  Google Scholar 

  • Tamai I, Ohashi R, Nezu J, et al (1998) Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J Biol Chem 273: 20378-20382.

    PubMed  CAS  Google Scholar 

  • Tamai I, Ohashi R, Nezu JI, et al (2000) Molecular and functional characterization of organic cation/carnitine transporter family in mice. J Biol Chem 275(51): 40064-40072.

    PubMed  CAS  Google Scholar 

  • Tamai I, China K, Sai Y, et al (2001) Na(+)-coupled transport of L-carnitine via high-affinity carnitine transporter OCTN2 and its subcellular localization in kidney. Bio chim Biophys Acta 1512: 273-284.

    CAS  Google Scholar 

  • Tang NL, Ganapathy V, Wu X, et al (1999) Mutations of OCTN2, an organic cation/carnitine transporter, lead to deficient cellular carnitine uptake in primary carnitine deficiency. Hum Mol Genet 8: 655-660.

    PubMed  CAS  Google Scholar 

  • Tein I, Xie ZW (1994) Reversal of valproic acid-associated impairment of carnitine uptake in cultured human skin fibroblasts. Biochem Biophys Res Commun 204: 753-758.

    PubMed  CAS  Google Scholar 

  • Tein I, Xie Z-W (1996) The human plasmalemmal carnitine transporter defect is expressed in cultured lymphoblasts: a new, rapid non-invasive diagnostic method for diagnosis. Clin Chim Acta 252: 1-4.

    Google Scholar 

  • Tein I, De Vivo DC, Bierman F, et al (1990) Impaired skin fibroblast carnitine uptake in primary systemic carnitine deficiency manifested by childhood carnitine-responsive cardiomyopathy. Pediatr Res 28: 247-255.

    PubMed  CAS  Google Scholar 

  • Tein I, DiMauro S, Xie Z-W, De Vivo DC (1993) Valproic acid impairs carnitine uptake in cultured human skin fibroblasts. An in vitro model for the pathogenesis of valproic acid-associated carnitine deficiency. Pediatr Res 34: 281-287.

    PubMed  CAS  Google Scholar 

  • Tein I, DiMauro S, Xie Z-W, De Vivo DC (1995) Heterozygotes for plasmalemmal carnitine transporter defect are at increased risk for valproic acid-associated impairment of carnitine uptake in cultured human skin fibroblasts. J Inherit Metab Dis 18: 313-322.

    PubMed  CAS  Google Scholar 

  • Tein I, Bukovac SW, Xie Z-W (1996) Characterization of the human plasmalemmal carnitine transporter in cultured skin fibroblasts. Arch Biochem Biophys 329: 145-155.

    PubMed  CAS  Google Scholar 

  • Toshimori K, Kuwajima M, Yoshinaga K, et al (1999) Dysfunctions of the epididymis as a result of primary carnitine deficiency in juvenile visceral steatosis mice. FEBS Lett 446: 323-326.

    PubMed  CAS  Google Scholar 

  • Treem WR, Stanley CA, Finegold DN, Hale DE, Coates PM (1988) Primary carnitine deficiency due to a failure of carnitine transport in kidney, muscle and fibroblasts. N Engl J Med 319: 1331-1336.

    PubMed  CAS  Google Scholar 

  • Turnbull DM, Bone AJ, Bartlett K, Koundakjian PP, Sherratt HS (1983) The effects of valproate on intermediary metabolism in isolated rat hepatocytes and intact rats. Biochem Pharmacol 15(32): 1887-1892.

    Google Scholar 

  • Uenaka R, Kuwajima M, Ono A, et al (1996) Increased expression of carnitine palmitoyltransferase I gene is repressed by administering L-carnitine in the hearts of carnitine-deficient juvenile visceral steatosis mice. J Biochem 119: 533-540.

    PubMed  CAS  Google Scholar 

  • Ullrich KJ (1994) Specificity of transporters for 'organic anions' and 'organic cations' in the kidney. Biochim Biophys Acta 1197: 45-62.

    PubMed  CAS  Google Scholar 

  • van Roermund CW, Hettema EH, van den Berg M, Tabak HF, Wanders RJ (1999) Molecular characterization of carnitine-dependent transport of acetyl-CoA from peroxisomes to mitochondria in Saccharomyces cerevisiae and identification of a plasma membrane carnitine transporter, Agp2p. EMBO J 18: 5843-5852.

    PubMed  CAS  Google Scholar 

  • Vary TC, Neely JR (1982) Characteristics of carnitine transport in isolated perfused adult rat hearts. Am J Physiol 242: H585-592.

    PubMed  CAS  Google Scholar 

  • Vaz FM, Scholte HR, Ruiter J, et al (1999) Identification of two novel mutations in OCTN2 of three patients with systemic carnitine deficiency. Hum Genet 105: 157-161.

    PubMed  CAS  Google Scholar 

  • Wagner CA, Lukewille U, Kaltenbach S, et al (2000) Functional and pharmacological characterization of human Na(+)-carnitine cotransporter hOCTN2. Am J Physiol Renal Physiol 279: F584-591.

    PubMed  CAS  Google Scholar 

  • Walker JE, Saraste M, Runswick MJ, Gay NJ (1982) Distantly related sequences in the alpha-and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold. EMBO J 1: 945-951.

    PubMed  CAS  Google Scholar 

  • Wang Y, Ye J, Ganapathy V, Longo N (1999) Mutations in the organic cation/carnitine trans-porter OCTN2 in primary carnitine deficiency. Proc Natl Acad Sci USA 96: 2356-2360.

    PubMed  CAS  Google Scholar 

  • Wang Y, Kelly MA, Cowan TM, Longo N (2000a) A missense mutation in the OCTN2 gene associated with residual carnitine transport activity. Hum Mutat 15: 238-245.

    PubMed  CAS  Google Scholar 

  • Wang Y, Taroni F, Garavaglia B, Longo N (2000b) Functional analysis of mutations in the OCTN2 transporter causing primary carnitine deficiency: lack of genotype phenotype correlation. Hum Mutat 16: 401-407.

    PubMed  CAS  Google Scholar 

  • Willner JH, Ginsburg S, DiMauro S (1978) Active transport of carnitine into skeletal muscle. Neurology 28: 721-724.

    PubMed  CAS  Google Scholar 

  • Wu X, Prasad PD, Leibach FH, Ganapathy V (1998) cDNA sequence, transport function and genomic organization of human OCTN2, a new member of the organic cation transporter family. Biochem Biophys Res Commun 246: 589-595.

    PubMed  CAS  Google Scholar 

  • Wu X, Huang W, Prasad PD, et al (1999) Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. J Pharmacol Exp Ther 290: 1482-1492.

    PubMed  CAS  Google Scholar 

  • Wu X, George RL, Huang W, et al (2000) Structural and functional characteristics and tissue distribution pattern of rat OCTN1, an organic cation transporter, cloned from placenta. Biochim Biophys Acta 1466: 315-327.

    PubMed  CAS  Google Scholar 

  • Yabuuchi H, Tamai I, Nezu J, et al (1999) Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations. J Pharmacol Exp Ther 289: 768-773.

    PubMed  CAS  Google Scholar 

  • Zevin S, Schaner ME, Illsley NP, Giacomini KM (1997) Guanidine transport in a human choriocarcinoma cell line (JAR). Pharm Res 14: 401-405.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Neurology, Department of Pediatrics, The Hospital for Sick Children, Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada

    I. Tein

Authors
  1. I. Tein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to I. Tein.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tein, I. Carnitine transport: Pathophysiology and metabolism of known molecular defects. J Inherit Metab Dis 26, 147–169 (2003). https://doi.org/10.1023/A:1024481016187

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1024481016187

Keywords

Search

Navigation